Glia · 1997 · 10 citations · 25 references
MedicineNeurobiologyNeuroscienceGlial BiologyNeuroimmunologyNeuropathologyDemyelinating DiseasesDemyelinating DisordersNervous TissueNeural DevelopmentOligodendrocyte BiologySpinal Cord PathologyAntibodiesMembrane GlycolipidsMyelin AntigensMyelin FormationMyelin LipidsMyelin Sheath Structure
It was shown previously (Rosenbluth et al.: J. Neurosci. 16:2635-2641, 1996) that implantation of hybridoma cells that produce an IgM antigalactocerebroside into the spinal cord of young rats results in the development of myelin sheaths with a repeat period approximately 2-3x normal, similar to the abnormal peripheral myelin sheaths seen in human IgM gammopathies. We now present evidence that this effect can be reproduced in the spinal cord by implanting either of two other hybridomas, O4 and A2B5, that secrete, respectively, antisulfatide and antiganglioside IgM antibodies. The formation of expanded CNS myelin thus does not depend on antibodies to galactocerebroside specifically but can be mediated by IgM antibodies that react with other myelin glycolipids as well.
25
The oligodendrocyte and its many cellular processes
S. E. Pfeiffer, Arthur E. Warrington, Rashmi Bansal · Trends in Cell Biology · 1993 · 841 citations
Medicine, Cell Biology, Neuroscience +12
Mice deficient for the glycoprotein show subtle abnormalities in myelin
Dirk Montag, Karl-Peter Giese, Udo Bartsch et al. · Neuron · 1994 · 376 citations
Medicine, Neurobiology, Neuroscience +14